The computer-aided discovery of novel family of the 5-HT6 serotonin receptor ligands among derivatives of 4-benzyl-1,3,5-triazine

被引:35
|
作者
Lazewska, Dorota [1 ]
Kurczab, Rafal [2 ]
Wiecek, Malgorzata [1 ]
Kaminska, Katarzyna [1 ]
Satala, Grzegorz [2 ]
Jastrebska-Wiesek, Magdalena [3 ]
Partyka, Anna [3 ]
Bojarski, Andrzej J. [2 ]
Wesolowska, Anna [3 ]
Kiec-Kononowicz, Katarzyna [1 ]
Handzlik, Jadwiga [1 ]
机构
[1] Jagiellonian Univ, Dept Technol & Biotechnol Drugs, Med Coll, Medyczna 9, PL-30688 Krakow, Poland
[2] Polish Acad Sci, Dept Med Chem, Inst Pharmacol, Smetna 12, PL-31343 Krakow, Poland
[3] Jagiellonian Univ, Dept Clin Pharm, Med Coll, Med 9, PL-30688 Krakow, Poland
关键词
Serotonin receptors; 5-HT6; ligands; 1,3,5-Triazine; Docking; CNS drugability; FORCED SWIMMING TEST; ANXIOLYTIC-LIKE; ANTIDEPRESSANT; ANTAGONISTS; POTENT; RATS; ADRENOCEPTOR; SB-399885; AFFINITY; AGONISTS;
D O I
10.1016/j.ejmech.2017.04.033
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The work describes a discovery of new chemical family of potent ligands for the 5-HT6 serotonin receptors. During the search for new histamine H-4 receptor antagonists among 1,3,5-triazine derivatives, compound 2 (4-benzyl-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-amine) was found. Compound 2, weakly active for the H4 receptor but fitted in 3/4 of pharmacophore features of the 5-HT6R ligand, occurred to be a moderate 5-HT6R agent, useful as a lead structure for further modifications. A series of new derivatives (3-19) of the lead 2 was synthesized, evaluated in the radioligand binding assay (RBA) and explored in comprehensive molecular modelling, including both pharmacophore- and structure based approaches with docking to the homology model of 5-HT6R. The most active compounds displayed a potent affinity for the 5-HT6R in the nanomolar range (K-i = 20-30 nM), some of them (4,11 and 19) were tested in the rat forced swim test that revealed their antidepressant-like effect. SAR-analysis on the basis of both, RBA and docking results, indicated that action on the receptor is related to the hydrophobicity and the size of aromatic moiety substituted by a methylene linker at the position 4 of 1,3,5-triazine. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:117 / 124
页数:8
相关论文
共 26 条
  • [21] N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists
    Cole, DC
    Ellingboe, JW
    Lennox, WJ
    Mazandarani, H
    Smith, DL
    Stock, JR
    Zhang, GM
    Zhou, P
    Schechter, LE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (02) : 379 - 383
  • [22] N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists
    Nirogi, Ramakrishna V. S.
    Konda, Jagadishu Babu
    Kambhampati, Ramasastry
    Shinde, Anil
    Bandyala, Thrinath Reddy
    Gudla, Parandhama
    Kandukuri, Kiran Kumar
    Jayarajan, Pradeep
    Kandikere, Vishwottam
    Dubey, P. K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (22) : 6980 - 6985
  • [23] Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists
    Hasui, Tomoaki
    Ohyabu, Norio
    Ohra, Taiichi
    Fuji, Koji
    Sugimoto, Takahiro
    Fujimoto, Jun
    Asano, Kouhei
    Oosawa, Masato
    Shiotani, Sachiko
    Nishigaki, Nobuhiro
    Kusumoto, Keiji
    Matsui, Hideki
    Mizukami, Atsushi
    Habuka, Noriyuki
    Sogabe, Satoshi
    Endo, Satoshi
    Ono, Midori
    Siedem, Christopher S.
    Tang, Tony P.
    Gauthier, Cassandra
    De Meese, Lisa A.
    Boyd, Steven A.
    Fukumoto, Shoji
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (19) : 5428 - 5445
  • [24] Discovery and Development of 1-[(2-Bromophenyl)sulfony1]-5methoxy-3-[(4-methyl-1-piperazinyl)methy1]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease
    Nirogi, Ramakrishna
    Shinde, Anil
    Kambhampati, Rama Sastry
    Mohammed, Abdul Rasheed
    Saraf, Sangram Keshari
    Mohammed, Abdul Rasheed
    Saraf, Sangram Keshari
    Badange, Rajesh Kumar
    Bandyala, Thrinath Reddy
    Bhatta, Venugopalarao
    Bojja, Kumar
    Reballi, Veena
    Subramanian, Ramkumar
    Benade, Vijay
    Palacharla, Raghava Choudary
    Bhyrapuneni, Gopinadh
    Jayarajan, Pradeep
    Goyal, Vinod
    Jasti, Venkat
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (05) : 1843 - 1859
  • [25] Novel difluoromethylated 1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-indole derivatives as potent 5-HT6 receptor antagonist with AMDE-improving properties: Design, synthesis, and biological evaluation
    Yi, Chao
    Chen, Kangzhi
    Liang, Haiping
    Wang, Zusheng
    Wang, Tao
    Li, Kai
    Yu, Jiahui
    Sun, Jiexie
    Jin, Chuanfei
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 71
  • [26] Synthesis, pharmacological evaluations, and molecular docking studies on a new 1,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine framework: Rigidification of D1 receptor selective 1-phenylbenzazepines and discovery of a new 5-HT6 receptor scaffold
    Giri, Rajan
    Alberts, Ian
    Harding, Wayne W.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2020, 96 (02) : 825 - 835